Direct providership by American Academy of Addiction Psychiatry
Adam Bisaga, MD | Professor of Psychiatry, Columbia University Medical Center, New York, NY
The third module highlights various aspects of maintenance treatment with naltrexone such as side-effects and safety concerns including ongoing opioid use and the risk of overdose. Clinical challenges seen during treatment with naltrexone and strategies to manage them are discussed as well as the management of relapse, treatment of pain, and mood effects. Finally, the module examines the logistics of using an injectable form of naltrexone.
- Describe the chronic disease model of opioid use disorder and the need for long-term pharmacological treatment
- Discuss common and serious side-effects that may occur during treatment with naltrexone
- Discuss safety concerns, particularly the risk for overdose, associated with naltrexone treatment
- Identify common clinical challenges and strategies to manage patients during early stages of treatment
- Demonstrate an understanding of logistics associated with XR-naltrexone treatment
Accreditation and Designation
American Academy of Addiction Psychiatry (AAAP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
American Academy of Addiction Psychiatry (AAAP) designates this enduring material for a maximum of 1 (one) AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs may claim a maximum of 1 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Method of participation in the learning process
In order to receive a maximum of 1 AMA PRA Category 1 Credit™, participants must participate in the entire module, answer post-test questions, pass with a 70% pass rate and complete an evaluation at the end of the activity.